Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)
Launched by POITIERS UNIVERSITY HOSPITAL · Aug 22, 2017
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
Evaluation of the feasibility of a new geriatric fragility screening tool (D-FOG) in patients aged ≥ 75 years during oncological treatment:
* Number of D-FOGs filled in: comparison with the number of patients included in the study and the number of visits of each patient.
* Regularity of the D-FOG self-questionnaire by the patient: comparison with the number of visits of the patient for a chemotherapy cure (HDJ or HDS).
* Number of criteria entered by D-FOG: comparison with the total number of criteria to be filled in
* Criterion analysis of D-FOG
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 75 years and over
- • Carriers of diagnosed cancer (excluding hematology)
- • Whatever the location, uniqueness or multiple, duration of development and treatment status (adjuvant, neoadjuvant, locally advanced or metastatic)
- • Seen in nursing consultant
- • Beginning an oncological treatment
- • Supported for oncology day hospital (HDJ) or weekly (HDS) chemotherapy
- • Patient not opposed to participate in the study
- Exclusion Criteria:
- • Patients under 75 years of age
- • Having not had an IDE ad consultation
- • During oncological treatment
- • Receiving Oral Therapy or hormone therapy alone
- • Treated by radiotherapy alone or surgery alone
- • Not attending a day or week oncology hospital
- • Refusal to participate in research
About Poitiers University Hospital
Poitiers University Hospital is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to explore new therapeutic interventions and improve patient outcomes. With a commitment to ethical standards and patient safety, Poitiers University Hospital collaborates with healthcare professionals, researchers, and institutions to facilitate groundbreaking studies that contribute to medical knowledge and enhance treatment protocols across various specialties.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Poitiers, , France
Patients applied
Trial Officials
VALERO SV SIMON, Doctor
Principal Investigator
CHU Poitiers
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials